DEA Extends Telehealth Flexibilities for Controlled Substance Prescribing Through 2025
- November 22, 2024
The Drug Enforcement Administration (DEA), for a third time, has extended telehealth flexibilities for prescribing controlled substances that were put in place during the COVID-19 pandemic.
ARTICLE TAGS
You must be logged in to access this content.